Adipose tissue-derived stem cells from affected and unaffected areas in patients with multiple symmetric lipomatosis show differential regulation of mTOR pathway genes.

CONCLUSIONS: Treatment with rapamycin might be a novel therapeutical approach for patients suffering from multiple symmetric lipomatosis.
PMID: 29758934 [PubMed - in process]

Source: Clinical Hemorheology and Microcirculation - May 17, 2018 Category: Hematology Authors: Felthaus O, Schön T, Schiltz D, Aung T, Kühlmann B, Jung F, Anker A, Klein S, Prantl L Tags: Clin Hemorheol Microcirc Source Type: research